ReviewCancer biology & therapy2020

Salvage camrelizumab plus apatinib for relapsed esophageal neuroendocrine carcinoma after esophagectomy: a case report and review of the literature.

Lei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.